Retroviral vectors for cancer gene therapy.
作者信息
Collins M
机构信息
Department of Immunology, Windeyer Institute of Medical Sciences, London, UK.
出版信息
Ernst Schering Res Found Workshop. 2000(30):99-104. doi: 10.1007/978-3-662-04183-3_6.
PMID:10943318
Abstract
摘要
相似文献
1
Retroviral vectors for cancer gene therapy.
Ernst Schering Res Found Workshop. 2000(30):99-104. doi: 10.1007/978-3-662-04183-3_6.
2
Gene therapy in human cancer: report of human clinical trials.
Cancer Invest. 2000;18(8):740-6. doi: 10.3109/07357900009012206.
3
Clinical trials involving multidrug resistance transcription units in retroviral vectors.
Clin Cancer Res. 1999 Jul;5(7):1607-9.
4
Gene therapy of cancer.
Lancet. 1997 May;349 Suppl 2:SII10-2. doi: 10.1016/s0140-6736(97)90013-1.
5
Improving the retroviral vector (RV) systems for immunotherapy of cancer.
Adv Exp Med Biol. 2001;495:389-92. doi: 10.1007/978-1-4615-0685-0_57.
6
Biosafety considerations using gamma-retroviral vectors in gene therapy.
Curr Gene Ther. 2013 Dec;13(6):469-77. doi: 10.2174/15665232113136660004.
7
Progress with retroviral gene vectors.
Rev Med Virol. 2000 May-Jun;10(3):185-202. doi: 10.1002/(sici)1099-1654(200005/06)10:3<185::aid-rmv285>3.0.co;2-8.
8
Retroviral vectors.
Mol Pathol. 2000 Aug;53(4):173-6. doi: 10.1136/mp.53.4.173.
9
Retroviral vectors for gene therapy.
Future Microbiol. 2010 Oct;5(10):1507-23. doi: 10.2217/fmb.10.100.
10
Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
Hum Gene Ther. 2001 Feb 10;12(3):315-20. doi: 10.1089/10430340150218440.
Zotero 插件